COVID-19 (SARS-CoV-2 infection) in health-care-workers and oncological/immunocompromised patients Infections and Infestations COVID-19 (SARS-CoV-2 infection)
Conditions
Interventions
Data on the participants’ sociodemographic and health characteristics will be collected using a questionnaire, and participants will be stratified by age, sex, and body mass index (BMI).
The mRNA va
Sponsors
Istituti Fisioterapici Ospitalieri
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Provided written informed consent 2. Oncological/immunocompromised patient at the Istituti Fisioterapici Ospitalieri (IFO) or health worker employed at the Istituti Fisioterapici Ospitalieri 3. Vaccinated at the Istituti Fisioterapici Ospitalieri
Exclusion criteria
Exclusion criteria: 1. Evidence of current or previous SARS-CoV-2 infection by either anamnesis, serological or microbiological test through nasopharyngeal swab before enrolment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Presence of antibodies measured using blood tests analysed by the LIAISON® SARS-CoV-2 S1/S2 IgG, test at baseline, 22 and 28 days, and every 30 days until the end of the study | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. SARS-CoV-2 infection measured using a nasopharyngeal swab analysed by SARS-CoV-2 RT-PCR testing at baseline, 22 and 28 days, and every 30 days until the end of the study | — |
Countries
Italy
Contacts
Public ContactRaul Pellini
Outcome results
None listed